Novartis chases rivals with next wave of cancer immunotherapy

Jan 25 (Reuters) - Novartis, lagging some other big

drugmakers in the first wave of immunotherapy drugs that are

revolutionising cancer treatment, hopes to catch up by focusing

on the next wave of immune system-boosting medicines.

Read more